Rasburicase administration can cause [[anaphylaxis]] (incidence unknown); [[methemoglobinemia]] may occur in susceptible individuals such as those with [[glucose-6-phosphate dehydrogenase deficiency|G6PDH deficiency]] due to the production of hydrogen peroxide in the urate oxidase reaction.<ref name="Wilson2012"/> Testing patients for G6PDH deficiency prior to starting a course of rasburicase has been recommended.<ref name="Wilson2012"/>

 

